Skip to Content

Vanguard Capital Opportunity Adm VHCAX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 188.62  /  +0.05 %
  • Total Assets 20.7 Bil
  • Adj. Expense Ratio
    0.360%
  • Expense Ratio 0.360%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 50,000
  • Status Limited
  • TTM Yield 0.75%
  • Turnover 6%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:18 PM GMT+0

Morningstar’s Analysis VHCAX

Will VHCAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

With its outstanding investment team and unique multimanager approach, Vanguard Capital Opportunity is exemplary.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VHCAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 30.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

9.47 2.0 Bil
Healthcare

Mktliq 12/31/2049

4.06 851.5 Mil
Cash and Equivalents

Amgen Inc

2.91 611.1 Mil
Healthcare

Biogen Inc

2.76 580.1 Mil
Healthcare

Microsoft Corp

2.51 526.9 Mil
Technology

Biomarin Pharmaceutical Inc

2.47 517.9 Mil
Healthcare

Flex Ltd

2.18 457.8 Mil
Technology

KLA Corp

2.11 443.9 Mil
Technology

Micron Technology Inc

2.02 423.5 Mil
Technology

FedEx Corp

1.99 417.2 Mil
Industrials